Rotenone remarkably attenuates oxidative stress, inflammation, and fibrosis in chronic obstructive uropathy

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Sun, Ying ^a,b   Zhang, Yue ^a   Zhao, Daqiang ^c   Ding, Guixia ^a   Huang, Songming ^a   Zhang, Aihua ^a   Jia, Zhanjun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBRONECTIN; HEME OXYGENASE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MITOCHONDRIAL DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE SUBUNIT 1\; ROTENONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; INFLAMMATION; KIDNEY FIBROSIS; MOUSE; NONHUMAN; OBSTRUCTIVE UROPATHY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNILATERAL URETERAL OBSTRUCTION; UPREGULATION; URETER OBSTRUCTION; ANIMAL; C57BL MOUSE; DRUG EFFECTS; FIBROSIS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; MALE; METABOLISM; URETERAL OBSTRUCTION;

ANIMALS; FIBROSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY DISEASES; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; ROTENONE; URETERAL OBSTRUCTION;

EID: 84913581800     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/670106     Document Type: Article

References (39)

1. A. A. Eddy, "Can renal fibrosis be reversed?" Pediatric Nephrology, vol. 20, no. 10, pp. 1369-1375, 2005.
2. M. El Nahas, "The global challenge of chronic kidney disease, " Kidney International, vol. 68, no. 6, pp. 2918-2929, 2005.
3. A. A. Eddy, "Molecular basis of renal fibrosis, " PediatricNephrology, vol. 15, no. 3-4, pp. 290-301, 2000.
4. G. Zheng, J. G. Lyons, K. T. Thian et al. , "Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-β1 in renal tubular epithelial cells, " American Journal of Pathology, vol. 175, no. 2, pp. 580-591, 2009.
5. K. Inazaki, Y. Kanamaru, Y. Kojima et al. , "Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction, " Kidney International, vol. 66, no. 2, pp. 597-604, 2004.
6. M. Madesh and G. Hajnoczky, "VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid andmassive cytochrome c release, " Journal of Cell Biology, vol. 155, no. 6, pp. 1003-1015, 2001.
7. P. Xie, L. Sun, B. Nayak et al. , "C/EBP-βmodulates transcription of tubulointerstitial nephritis antigen in obstructive uropathy, " Journal of the American Society of Nephrology, vol. 20, no. 4, pp. 807-819, 2009.
8. J. Rojas-Rivera, A. Ortiz, and J. Egido, "Antioxidants in kidney diseases: the impact of bardoxolone methyl, " International Journal ofNephrology, vol. 2012, Article ID321714, 11pages, 2012.
9. D. Impellizzeri, E. Esposito, J. Attley, and S. Cuzzocrea, "Targeting inflammation: new therapeutic approaches in chronic kidney disease (CKD), " Pharmacological Research, vol. 81, pp. 91-102, 2014.
10. I. M. Garcia, L. Altamirano, L. Mazzei et al. , "Role ofmitochondria in paricalcitol-mediated cytoprotection during obstructive nephropathy, " The American Journal of Physiology-Renal Physiology, vol. 302, no. 12, pp. F1595-F1605, 2012.
11. D. M. Small, J. S. Coombes, N. Bennett, D. W. Johnson, and G. C. Gobe, "Oxidative stress, anti-oxidant therapies and chronic kidney disease, " Nephrology, vol. 17, no. 4, pp. 311-321, 2012.
12. Y. Xu, S. Ruan, X. Wu, H. Chen, K. Zheng, and B. Fu, "Autophagy and apoptosis in tubular cells following unilateral ureteral obstruction are associated with mitochondrial oxidative stress, " International Journal of Molecular Medicine, vol. 31, no. 3, pp. 628-636, 2013.
13. J. F. Chen, H. Liu, H. F. Ni et al. , "Improved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized rats, " PLoS ONE, vol. 8, no. 12, Article IDe83593, 2013.
14. R. Dhingra and L. A. Kirshenbaum, "Regulation of mitochondrial dynamics and cell fate, " Circulation Journal, vol. 78, pp. 803-810, 2014.
15. A. Devin and M. Rigoulet, "Mechanisms of mitochondrial response to variations in energy demand in eukaryotic cells, " The American Journal of Physiology-Cell Physiology, vol. 292, no. 1, pp. C52-C58, 2007.
16. S. Michel, A. Wanet, A. de Pauw, G. Rommelaere, T. Arnould, and P. Renard, "Crosstalk between mitochondrial (dys)function and mitochondrial abundance, " Journal of Cellular Physiology, vol. 227, no. 6, pp. 2297-2310, 2012.
17. E. M. V. deCavanagh, F. Inserra, M. Ferder, and L. Ferder, "From mitochondria to disease: role of the renin-angiotensin system, " American Journal ofNephrology, vol. 27, no. 6, pp. 545-553, 2007.
18. M. Su, A. Dhoopun, Y. Yuan et al. , "Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury, " The American Journal of Physiology: Renal Physiology, vol. 305, no. 4, pp. F520-F531, 2013.
19. R. L. Chevalier, M. S. Forbes, and B. A. Thornhill, "Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy, " Kidney International, vol. 75, no. 11, pp. 1145-1152, 2009.
20. K. M. A. Rouschop, M. E. Sewnath, N. Claessen et al. , "CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy, " Journal of the American Society of Nephrology, vol. 15, no. 3, pp. 674-686, 2004.
21. Z. Jia, H. Wang, and T. Yang, "Microsomal prostaglandin E synthase 1 deletion retards renal disease progression but exacerbates anemia in mice with renal mass reduction, " Hypertension, vol. 59, no. 1, pp. 122-128, 2012.
22. S. S. Badal and F. R. Danesh, "New insights into molecular mechanisms of diabetic kidney disease, " American Journal of Kidney Diseases, vol. 63, pp. S63-S83, 2014.
23. M. E. Hall, J. M. doCarmo, A. A. da Silva, L. A. Juncos, Z. Wang, and J. E. Hall, "Obesity, hypertension, and chronic kidney disease, " International Journal of Nephrology and Renovascular Disease, vol. 7, pp. 75-88, 2014.
24. D. B. Zorov, C. R. Filburn, L. O. Klotz, J. L. Zweier, and S. J. Sollott, "Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes, " Journal of Experimental Medicine, vol. 192, no. 7, pp. 1001-1014, 2000.
25. Y. R. Chen and J. L. Zweier, "Cardiac mitochondria and reactive oxygen species generation, " Circulation Research, vol. 114, no. 3, pp. 524-537, 2014.
26. M. E. Witte, D. J. Mahad, H. Lassmann, and J. van Horssen, "Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis, " Trends in Molecular Medicine, vol. 20, pp. 179-187, 2014.
27. D. C. Wallace, "Mitochondrial diseases in man and mouse, " Science, vol. 283, no. 5407, pp. 1482-1488, 1999.
28. D. C. Wallace, "A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine, " Annual Review of Genetics, vol. 39, pp. 359-407, 2005.
29. M. S. Forbes, B. A. Thornhill, C. I. Galarreta, J. J. Minor, K. A. Gordon, and R. L. Chevalier, "Chronic unilateral ureteral obstruction in the neonatal mouse delays maturation of both kidneys and leads to late formation of atubular glomeruli, " American Journal of Physiology: Renal Physiology, vol. 305, pp. F1736-F1746, 2013.
30. G. F. Schreiner, K. P. G. Harris, M. L. Purkerson, and S. Klahr, "Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney, " Kidney International, vol. 34, no. 4, pp. 487-493, 1988.
31. Y. Le Meur, G. H. Tesch, P. A. Hill et al. , "Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway, " Journal of Leukocyte Biology, vol. 72, no. 3, pp. 530-537, 2002.
32. D. M. Lenda, E. Kikawada, E. R. Stanley, and V. R. Kelley, "Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation, " Journal of Immunology, vol. 170, no. 6, pp. 3254-3262, 2003.
33. J. M. Vieira Jr. , E. Mantovani, L. Tavares Rodrigues et al. , "Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction, " Nephrology Dialysis Transplantation, vol. 20, no. 8, pp. 1582-1591, 2005.
34. Y. Li, R. F. Schwabe, T. DeVries-Seimon et al. , "Free cholesterolloaded macrophages are an abundant source of tumor necrosis factor-α and interleukin-6: model of NF-αB-and map kinasedependent inflammation in advanced atherosclerosis, "TheJournal of Biological Chemistry, vol. 280, no. 23, pp. 21763-21772, 2005.
35. S. Klahr and J. Morrissey, "Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor, " Kidney International, Supplement, vol. 64, no. 87, pp. S105-S112, 2003.
36. M. Sato, Y. Muragaki, S. Saika, A. B. Roberts, and A. Ooshima, "Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction, " Journal of Clinical Investigation, vol. 112, no. 10, pp. 1486-1494, 2003.
37. F. J. Lopez-Hernandez and J. M. Lopez-Novoa, "Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects, " Cell and Tissue Research, vol. 347, no. 1, pp. 141-154, 2012.
38. H. B. Lee, M. R. Yu, Y. Yang, Z. Jiang, and H. Ha, "Reactive oxygen species-regulated signaling pathways in diabetic nephropathy, " Journal of theAmericanSociety ofNephrology, vol. 14, no. 3, pp. S241-S245, 2003.
39. D. E. Sullivan, M. Ferris, H. Nguyen, E. Abboud, and A. R. Brody, "TNF-α induces TGF-β1 expression in lung fibroblasts at the transcriptional level via AP-1 activation, " Journal of Cellular and Molecular Medicine, vol. 13, no. 8 B, pp. 1866-1876, 2009.